NIBP (Non-invasive Blood Pressure) Algorithm Enhancements (Characterize the Robustness of Motion Artifact Suppression)

  • days left to enroll
  • participants needed
  • sponsor
    Philips Clinical & Medical Affairs Global
Updated on 7 October 2022


The study intervention consists of a non-invasive blood pressure (NIBP) measurement device and cuff (FDA-cleared Philips IntelliVue X3 Rev. N.04 patient monitor) running a non-approved modified software containing an enhanced measurement algorithm for NIBP.


The purpose of this study is to compare measurements of NIBP taken by the study device and measurements taken by the current FDA-approved algorithm included in Rev. N.0 software for the IntelliVue patient monitors during motion artifact in patients undergoing caesarian section deliveries under epidural anesthesia.

Condition Movement, Involuntary
Treatment Philips IntelliVue X3 patient monitor with investigational NIBP measurement algorithm (measured once per 3 minutes)
Clinical Study IdentifierNCT05185037
SponsorPhilips Clinical & Medical Affairs Global
Last Modified on7 October 2022


Yes No Not Sure

Inclusion Criteria

Obstetric patient at Yale New Haven Hospital
Receiving epidural anesthesia
Age at least 18 years
Willing and able to provide informed consent in a Sponsor approved language
Willing and able to comply with study-related procedures
Priority classification II, III, or IV

Exclusion Criteria

Non-caesarian section deliveries
Ruptured uterus, prolonged fetal bradycardia, cord prolapse, or other emergent condition
Procedures under general anesthesia
Altered mental status
Currently participating in another clinical trial with any product, treatment and/or medication that clinically interferes with the study endpoint(s)
Priority classification I or V
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note